Grilley-Olson, J. E.
Bedard, P. L.
Fasolo, A.
Cornfeld, M.
Cartee, L.
Razak, A. R. Abdul
Stayner, L.-A.
Wu, Y.
Greenwood, R.
Singh, R.
Lee, C. B.
Bendell, J.
Burris, H. A.
Del Conte, G.
Sessa, C.
Infante, J. R.
Article History
Received: 3 June 2016
Accepted: 11 July 2016
First Online: 23 July 2016
Compliance with ethical standards
:
: This study was funded by GlaxoSmithKline. Rajendra Singh and Yuehui Wu are current employees/stockholders of GlaxoSmithKline. Leanne Cartee is a former employee and current stockholder of GlaxoSmithKline. Philippe Bedard has received research funding from GlaxoSmithKine and Novartis. Albiruni Razak has received travel funding from GlaxoSmithKline, Novartis, BristolMyersSquibb, Boehringer, Karyopharm, and Deciphera. All remaining authors declare no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Written informed consent was obtained from all participants included in the study.